SSRIs
Limiting doses of citalopram
As a hospital or community pharmacist, you will hear about limiting doses of citalopram ( Cipram , etc). Experts say citalopram doses should not exceed 40 mg/day for anyone, or 20 mg/day for most patients over age 60. Higher doses of citalopram increase the risk of QT prolongation and the life-threatening arrhythmia, torsades. …
قراءة المزيد
Neurology and Psychiatry
Atypical antipsychotics will be used more for treating depression
As a pharmacist, don't be surprised if you see atypical antipsychotics being used more often in treating depression. Both aripiprazole ( Abilify ) and olanzapine/fluoxetine ( Symbyax ) are already approved for resistant depression and quetiapine ( Seroquel ) will likely get a similar indication. More than half of patients with depression still have symptoms despi…
قراءة المزيد
SSRIs
Depression and cardiovascular disease
Introduction ― Depression is common in patients with cardiovascular (CV) disease. Symptoms of depression are seen in 65% of patients after an acute myocardial infarction (MI). Major depressive disorder is diagnosed in up to 20% of patients after an acute coronary syndrome. Depression is associated with a doubling in the risk of a cardiovascular event within one to t…
قراءة المزيد
SSRIs
Address depression in patients after a heart attack
How to treat depression after a heart attack? this is important questions. Depression occurs in nearly half of heart attack patients and it's associated with a higher risk of CV events and death. Plus adherence to lifestyle changes and cardiovascular medications, antiplatelets, statins, etc may be even harder for patients with depression. But don't recommend …
قراءة المزيد
Social Plugin